Essayer OR - Gratuit

Why are global markets so complacent?

Business Standard

|

October 26, 2024

The world is beset with risks - political, geo-political, fiscal and monetary. But markets choose to look the other way, either being blissfully oblivious or wantonly negligent

- SAJJID Z CHINOY

Why are global markets so complacent?

Equity markets around the world continue to be on a tear. The MSCI Global Equity Index is close to its lifetime highs, up a staggering 30 per cent over the last year. But it is not just equities; all asset classes have thrived in recent months.

Yields may have backed up in recent weeks but United States rates are still pricing in lots of Federal Reserve cuts over the next year. And credit spreads remain very modest. So financial conditions in the US are very benign and have gotten progressively easier as reflected, for example, in the Chicago Fed's Financial Conditions Index.

This buoyancy is not limited to advanced economies. Emerging Market (EM) equities are also up almost 25 per cent over the last year and many EM currencies have rallied against the dollar over the last three months.

But why should we be surprised? Isn't the US firmly on its way to a soft landing? Or perhaps, no landing at all, given the sheer resilience of US growth? Hasn't China finally pulled out all the stops to jumpstart growth? Isn't the Fed in the midst of a large cutting cycle that will induce EM central banks to cut in tandem? In short, aren't we in macroeconomic "Goldilocks" land?

Or, are we? A more sober assessment of the data suggests the enthusiasm of global markets sits uneasily with a more uncomfortable economic reality that is peppered with a litany of political, geopolitical, fiscal and monetary risks.

To be clear, US growth has been resilient beyond expectation. Defying all forecasts, gross domestic product (GDP) growth is remarkably on track to print close to 3 per cent again this year. Prima facie, this is good news for the economy and equity markets, but it risks making the last mile of disinflation harder.

PLUS D'HISTOIRES DE Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size